The activation of STAT3 was markedly increased by a W775 stop germline mutation of protein tyrosine phosphatase delta, a tumor suppressor, identified in 37.5% of metastatic ES patients (Veeriah et al., 2009; Jiang et al., 2013; Jiang et al., 2014). The gene discussed is STAT3; the disease is Ewing sarcoma.